156 related articles for article (PubMed ID: 38545226)
1. Gadolinium deposition in the liver and brain in a rat model with liver fibrosis after intravenous administration of gadoxetate disodium.
Wei P; Hu Q; He C; Hua P; Yang D; Shao C; Xie L; Han Z; Zhou X; Ding Z; Hu H
Heliyon; 2024 Mar; 10(6):e27419. PubMed ID: 38545226
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium accumulation and fibrosis in the liver after administration of gadoxetate disodium in a rat model of active hepatic fibrosis.
Hope TA; Doherty A; Fu Y; Aslam R; Qayyum A; Brasch RC
Radiology; 2012 Aug; 264(2):423-7. PubMed ID: 22570507
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Speciation Analysis of Residual Gadolinium in Deep Cerebellar Nuclei in Rats Repeatedly Administered With Gadoterate Meglumine or Gadodiamide.
Strzeminska I; Factor C; Jimenez-Lamana J; Lacomme S; Subirana MA; Le Coustumer P; Schaumlöffel D; Robert P; Szpunar J; Corot C; Lobinski R
Invest Radiol; 2022 May; 57(5):283-292. PubMed ID: 35066532
[TBL] [Abstract][Full Text] [Related]
5. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
6. Ischemic Stroke Increased Gadolinium Deposition in the Brain and Aggravated Astrocyte Injury After Gadolinium-Based Contrast Agent Administration: Linear Versus Macrocyclic Agents.
Huang XX; Jiang RH; Xu XQ; Zu QQ; Wu FY; Liu S; Shi HB
J Magn Reson Imaging; 2021 Apr; 53(4):1282-1292. PubMed ID: 33555617
[TBL] [Abstract][Full Text] [Related]
7. Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Sato T; Tamada T; Watanabe S; Nishimura H; Kanki A; Noda Y; Higaki A; Yamamoto A; Ito K
Radiol Med; 2015 Jun; 120(6):557-62. PubMed ID: 25572545
[TBL] [Abstract][Full Text] [Related]
8. Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine.
Violas X; Rasschaert M; Santus R; Factor C; Corot C; Catoen S; Idée JM; Robert P
Invest Radiol; 2022 Feb; 57(2):130-139. PubMed ID: 34411032
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
[TBL] [Abstract][Full Text] [Related]
10. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
Fretellier N; Granottier A; Rasschaert M; Grindel AL; Baudimont F; Robert P; Idée JM; Corot C
Invest Radiol; 2019 Feb; 54(2):61-71. PubMed ID: 30394964
[TBL] [Abstract][Full Text] [Related]
11. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats.
Bussi S; Coppo A; Bonafè R; Rossi S; Colombo Serra S; Penard L; Kirchin MA; Maisano F; Tedoldi F
J Magn Reson Imaging; 2021 Nov; 54(5):1636-1644. PubMed ID: 33973290
[TBL] [Abstract][Full Text] [Related]
13. Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.
Robert P; Violas X; Grand S; Lehericy S; Idée JM; Ballet S; Corot C
Invest Radiol; 2016 Feb; 51(2):73-82. PubMed ID: 26606549
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Gadolinium-Based Contrast Agents on Longitudinal Changes of Magnetic Resonance Imaging Signal Intensities and Relaxation Times in the Aging Rat Brain.
Green C; Jost G; Frenzel T; Boyken J; Schwenke C; Pietsch H
Invest Radiol; 2022 Jul; 57(7):453-462. PubMed ID: 35125411
[TBL] [Abstract][Full Text] [Related]
15. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium-Based Contrast Agents.
Yao X; Zhang H; Shi D; Li Y; Guo Q; Yu Z; Wang S; Ren K
J Magn Reson Imaging; 2022 Sep; 56(3):835-845. PubMed ID: 35166409
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of the Spatial Distribution of Gadolinium, Iron, Manganese, and Phosphorus in the Brain of Healthy Rats After High-Dose Administrations of Gadodiamide and Gadobutrol.
Hummel L; Frenzel T; Boyken J; Pietsch H; Seeliger E
Invest Radiol; 2024 Feb; 59(2):150-164. PubMed ID: 38157437
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium Tissue Distribution in a Large-Animal Model after a Single Dose of Gadolinium-based Contrast Agents.
Richter H; Bücker P; Martin LF; Dunker C; Fingerhut S; Xia A; Karol A; Sperling M; Karst U; Radbruch A; Jeibmann A
Radiology; 2021 Dec; 301(3):637-642. PubMed ID: 34546128
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gadolinium deposition in the brain structures with signal intensity increase after intravenous application.
Holesta M; Weichet J; Wagnerova MG; Lukavsky J; Malikova H
Neurol India; 2018; 66(6):1771-1775. PubMed ID: 30504579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
